Propiedad y actividad de insiders de Outlook Therapeutics, Inc. (OTLK): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.68 |
| Capitalización | $127M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $2.4M | $3.2M | $1.7M | $8.0M | $12.5M | $14.5M | $17.4M | $23.4M | $14.9M | $8.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.5M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.3M |
| Activos Corrientes | $5.7M | $3.9M | $3.3M | $13.5M | $17.9M | $21.5M | $27.5M | $31.0M | $27.4M | $17.4M |
| Inmovilizado Material | $17.0M | $16.1M | $18.5M | $3.2M | $494235 | $275054 | $70360 | $26172 | $274645 | $225508 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $23.7M | $20.7M | $22.3M | $17.1M | $19.7M | $22.8M | $28.5M | $32.3M | $28.8M | $18.6M |
| Cuentas por Pagar | $5.1M | $11.0M | $3.6M | $2.3M | $2.4M | $2.2M | $3.5M | $6.6M | $8.0M | $10.2M |
| Deuda a Corto | $5.2M | $4.7M | $17.9M | $11.3M | $3.7M | $904200 | $10.9M | $35.6M | $29.4M | $29.9M |
| Pasivos Corrientes | $20.4M | $28.7M | $32.0M | $20.3M | $15.9M | $6.8M | $19.7M | $46.7M | $42.6M | $45.8M |
| Deuda a Largo | $2.2M | $13.4M | $98487 | $50285 | $904200 | $10.9M | 0 | 0 | 0 | 0 |
| Pasivos Totales | $28.9M | $51.5M | $43.1M | $27.9M | $16.9M | $18.2M | $19.8M | $46.7M | $101.9M | $50.8M |
| Reservas | -$147.4M | -$186.2M | -$216.3M | -$254.5M | -$289.7M | -$342.9M | -$408.9M | -$467.9M | -$543.3M | -$605.7M |
| Patrimonio Neto | -$5.2M | -$30.7M | -$20.8M | -$10.8M | $2.8M | $4.6M | $8.7M | -$14.4M | -$73.1M | -$32.2M |
| Deuda Total | $8.7M | $18.4M | $21.9M | $14.9M | $8.8M | $11.9M | $11.0M | $35.6M | $29.7M | $30.2M |
| Deuda Neta | $6.4M | $15.2M | $20.2M | $6.9M | -$3.7M | -$2.6M | -$6.4M | $12.2M | $14.8M | $22.1M |
| Capital Circulante | -$14.8M | -$24.8M | -$28.7M | -$6.8M | $2.1M | $14.8M | $7.8M | -$15.8M | -$15.1M | -$28.4M |
Salud financiera
| Deuda / Patrimonio | -1.77 |
| Ratio corriente | 0.81 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -58.86 |
Rentabilidad
| Rentabilidad sobre capital | 222.01% |
| Rentabilidad sobre capital invertido | -343.68% |
| Rentabilidad sobre activos | -233.43% |
| Margen bruto | 195.64% |
| Margen operativo | 4783.05% |
| Margen neto | 5254.81% |
Empresas relacionadas: COEP · CUE · EQ · HOWL · IOBT · IPSC · MDCX
Explorar sector: Healthcare · Biotechnology
Más secciones de OTLK: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones